Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Prospective, Multicenter, Controlled Study With Blinded Assessment to Determine the Safety and Effectiveness of the Sebacia Acne Treatment System in the Treatment of Inflammatory Acne Vulgaris

NCT02217228 is registered in ClinicalTrials.gov with Sebacia, Inc. as lead sponsor.

NCT NCT02217228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02217228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Prospective, Multicenter, Controlled Study With Blinded Assessment to Determine the Safety and Effectiveness of the Sebacia Acne Treatment System in the Treatment of Inflammatory Acne Vulgaris
Lead sponsor
Sebacia, Inc.
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2014
Completion date
December 31, 2015
Enrollment
394 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory acne vulgaris